CohBar, Inc. (NASDAQ:CWBR – Get Free Report) shares were up 4.7% during trading on Monday . The stock traded as high as $0.51 and last traded at $0.51. Approximately 155 shares were traded during mid-day trading, a decline of 93% from the average daily volume of 2,369 shares. The stock had previously closed at $0.49.
CohBar Price Performance
The company has a fifty day moving average price of $0.49 and a 200-day moving average price of $0.53.
CohBar Company Profile
CohBar, Inc, a clinical stage biotechnology company, develops mitochondria and peptides based therapeutics for the treatment of chronic and age-related diseases. It develops CB4211, a therapeutic that is in Phase 1a/1b clinical trial for the treatment of nonalcoholic steatohepatitis and obesity; and CB5138 Analogs, which is in preclinical study to treat idiopathic pulmonary fibrosis and other fibrotic diseases.
See Also
- Five stocks we like better than CohBar
- Insider Trading – What You Need to Know
- Target Results Are Not a Retail Bellwether: Why the Dip Is a Buy
- Stock Ratings and Recommendations: Understanding Analyst Ratings
- Williams-Sonoma Stock: Buy It and Never Let It Go
- REIT Stocks – Best REIT Stocks to Add to Your Portfolio Today
- 5 Dividend ETFs to Buy and Hold Forever
Receive News & Ratings for CohBar Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CohBar and related companies with MarketBeat.com's FREE daily email newsletter.
